Diphtheria-Tetanus-Pertussis Vaccine
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Diphtheria-Tetanus-Pertussis Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D015721
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D20.215.894.135.535.300 D20.215.894.691.263.300 D20.215.894.691.824.300 D20.215.894.815.300 
						 | 
					
					
						| Concept/Terms | 
						
							Diphtheria-Tetanus-Pertussis Vaccine- Diphtheria-Tetanus-Pertussis Vaccine
 - Diphtheria Tetanus Pertussis Vaccine
 - Vaccine, Diphtheria-Tetanus-Pertussis
 - DTwP Vaccine
 - Vaccine, DTwP
 - DPT Vaccine
 - Vaccine, DPT
 - DTP Vaccine
 - Vaccine, DTP
 - Di-Te-Per Vaccine
 - Di Te Per Vaccine
 - Vaccine, Di-Te-Per
 - Diphtheria-Pertussis-Tetanus Vaccine
 - Diphtheria Pertussis Tetanus Vaccine
 - Vaccine, Diphtheria-Pertussis-Tetanus
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-Pertussis Vaccine".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-Pertussis Vaccine".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in this website by year, and whether "Diphtheria-Tetanus-Pertussis Vaccine" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 1996 | 1 | 0 | 1 | 
| 2005 | 0 | 1 | 1 | 
| 2009 | 1 | 0 | 1 | 
| 2010 | 1 | 0 | 1 | 
| 2012 | 1 | 0 | 1 | 
| 2013 | 1 | 0 | 1 | 
| 2014 | 1 | 0 | 1 | 
| 2015 | 1 | 0 | 1 | 
| 2016 | 1 | 1 | 2 | 
| 2017 | 1 | 0 | 1 | 
| 2020 | 0 | 1 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in Profiles.
						
					
								- 
								
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. Vaccine. 2021 03 05; 39(10):1534-1543.
															
								 
							
								- 
								
Vaccine adverse events in a safety net healthcare system and a managed care organization. Vaccine. 2017 03 01; 35(9):1335-1340.
															
								 
							
								- 
								
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants. Pediatr Infect Dis J. 2017 02; 36(2):202-208.
															
								 
							
								- 
								
Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis. Clin Infect Dis. 2016 Dec 01; 63(11):1456-1462.
															
								 
							
								- 
								
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine. 2016 07 29; 34(35):4172-4179.
															
								 
							
								- 
								
A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015 Apr; 11(4):e1004138.
															
								 
							
								- 
								
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014 May 07; 311(17):1760-9.
															
								 
							
								- 
								
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
															
								 
							
								- 
								
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
															
								 
							
								- 
								
Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012 Sep 13; 367(11):1012-9.